Sweta Shah

22 papers receiving 250 citations

Peers

Sweta Shah
Comparison fields: 5 of 65
  • Molecular Biology 96
  • Oncology 84
  • Infectious Diseases 55
  • Epidemiology 47
  • Molecular Medicine 45
Replace Kristina Nadrah with:
Kristina Nadrah Slovenia
Joan Antoni Schoenenberger-Arnaiz Spain
Subasree Srinivasan United States
Yishu Tang China
Mohammad Faheem Pakistan
Tilman Lingscheid Germany
Julien Senécal Canada
Sabrina Beltramini Italy
Estela Moreno-García Spain
Jose C. Granados United States
Sweta Shah relative to Kristina Nadrah Slovenia Kristina Nadrah's profile →
Citations per field
00.5×2.9×
Kristina Nadrah · 1×
Citations per year

Countries citing papers authored by Sweta Shah

Since Specialization
Citations

This map shows the geographic impact of Sweta Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sweta Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sweta Shah more than expected).

Fields of papers citing papers by Sweta Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sweta Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sweta Shah. The network helps show where Sweta Shah may publish in the future.

Co-authorship network of co-authors of Sweta Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Sweta Shah. A scholar is included among the top collaborators of Sweta Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sweta Shah. Sweta Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 1
5 2
6 28
7 2
8 5
9 5
10 9
11 12
12 11
13 18
14 10
15 5
16 15
17
COLISTIN-CARBAPENEM COMBINATION THERAPY AGAINST CARBAPENEM RESISTANT GRAM NEGATIVE BACILLI INFECTIONS: CLINICAL AND AN IN VITRO SYNERGY STUDY
5
18 3
19 2
20 117

About Sweta Shah

Sweta Shah is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Infectious Diseases, having authored 25 papers that have together received 265 indexed citations. Recurring topics across this work include Infection Control in Healthcare (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (35 citations), Molecular Medicine (45 citations) and Clinical Biochemistry (24 citations). Sweta Shah has collaborated with scholars based in India, United States and South Korea. Frequent co-authors include Tanu Singhal, Reshma Naik, Grantland Hillman, Rachel Langland, Suzanne Cheng, Lin Wu, H. Jeffrey Lawrence, Stephen Soviero, Rajeev Soman and Nita Munshi. Their work appears in journals such as American Journal of Respiratory and Critical Care Medicine, American Journal of Infection Control and Diagnostic Microbiology and Infectious Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026